Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Promoter specificity and stability control of the p53-related protein p73

Abstract

The p53 family of proteins play instrumental roles in mediating the cellular response to stress. The p53-related gene product, p73, occurs as two distinct protein isoforms, referred to as α and β, which differ in the length of the C-terminal region and arise through alternative splicing of the p73 RNA. Here, we describe an analysis of the transcription properties of p73 and show that although there are certain similarities between transcriptional activation mediated by p73 and p53, such as in their sensitivity to adenovirus E1A and the requirement for p300/CBP co-activator proteins, significant differences are apparent in the response mechanisms. Thus, we find that p73 shows a degree of specificity for the promoters of target genes that is quantitatively distinct from the response mediated by p53. For example, p73 activates the GADD45 gene more efficiently than p53, whereas the reverse situation was apparent for the p21 gene. These effects are, in part, due to the influence of a regulatory domain present in the extended C-terminal of the α isoform. Moreover, we provide evidence that this domain regulates protein abundance by influencing the proteasome-dependent degradation of p73. These data define a novel level of isoform-specific control in regulating p73 activity, and thereby highlight a significant difference between the mechanisms that govern the transcriptional activity of p53 and p73.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS and Kelly K. . 1997 Cell 89: 1175–1184.

  • Chen X, Bargonetti J and Prives C. . 1995 Cancer Res. 55: 4257–4263.

  • Chen X, Ko LJ, Jayaraman L and Prives C. . 1996 Genes Dev. 10: 2438–2451.

  • Crook T, Marston NJ, Sara EA and Vousden KH. . 1994 Cell 79: 817–827.

  • de Oca Luna RM, Wagner DS and Lozano G. . 1995 Nature 378: 203–206.

  • Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ and Reed SI. . 1994 Cell 76: 1013–1023.

  • Eckner R, McEwan ME, Newsome D, Gerdes M, DeCaprio JA, Lawrence JB and Livingston DM. . 1994 Genes Dev. 8: 869–884.

  • El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler K and Vogelstein B. . 1993 Cell 75: 817–825.

  • Friedlander P, Haupt Y and Oren M. . 1996 Mol. Cell. Biol. 16: 4961–4971.

  • Gaiccia AJ and Kastan MB. . 1998 Genes Dev. 12: 2973–2983.

  • Gu W and Roeder RG. . 1997 Cell 90: 595–606.

  • Gu W, Shi X-L and Roeder RG. . 1997 Nature 387: 819–822.

  • Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ. . 1993 Cell 75: 805–816.

  • Haupt Y, Maya R, Kazaz A and Oren M. . 1997 Nature 387: 296–299.

  • Hoffman F, Martelli F, Livingston DM and Wang Z. . 1996 Genes Dev. 10: 2949–2959.

  • Hupp TR, Meek DW, Midgley CA and Lane DP. . 1992 Cell 71: 875–886.

  • Jones SN, Roe AE, Donehower LA and Bradley AB. . 1995 Nature 378: 206–208.

  • Jost CA, Marin MC and Kaelin Jr WG. . 1997 Nature 389: 191–194.

  • Kaghad M, Bonnet H, Yang A, Creancier L, Biscan J-C, Valent A, Minty A, Chalon P, Lelias J-M, Dumont X, Ferrara P, McKeon F and Caput D. . 1997 Cell 90: 809–819.

  • Ko L-J and Prives C. . 1996 Genes Dev. 10: 1054–1072.

  • Kraus VB, Moran E and Nevins JR. . 1992 Mol. Cell. Biol. 12: 4391–4399.

  • Kubbutat MHG, Jones SN and Vousden KH. . 1997 Nature 387: 299–303.

  • Lee C-W, Sørensen TS, Shikama N and La Thangue NB. . 1998 Oncogene 16: 2695–2710.

  • Levine AJ. . 1997 Cell 88: 323–331.

  • Lill NL, Grossman SR, Ginsberg D, DeCaprio J and Livingston DM. . 1997 Nature 387: 823–827.

  • Mai M, Yokimozo A, Qian C, Yang P, Tindall DJ, Smith DI and Liu W. . 1998 Cancer Res. 58: 2347–2349.

  • Marim MC, Jost CA, Irwin MS, DeCaprio JA, Caput D and Kaelin Jr WG. . 1998 Mol. Cell. Biol. 18: 6313–6324.

  • Momand J, Zambetti GP, Olson DC, George D and Levine AJ. . 1992 Cell 69: 1237–1245.

  • Notomo S, Haruki N, Kondo M, Konishi H, Takahashi T, Takahashi T and Takahashi T. . 1998 Cancer Res. 58: 1380–1383.

  • Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW and Vogelstein B. . 1993 Nature 362: 857–860.

  • Oren M. . 1997 Cell 90: 829–832.

  • Osada M, Ohba M, Kawahara C, Ishioka C, Kanamura R, Katoh I, Ikawa Y, Nimura Y, Nakagawara A, Obinata M and Ikawa S. . 1998 Nature Med. 4: 839–843.

  • Pietenpol JA, Tokino T, Thiagalingam S, El-Deiry W, Kinzler KW and Vogelstein B. . 1994 Proc. Natl. Acad. Sci. USA 91: 1998–2002.

  • Prabhu NS, Somasundaram K, Satyamoorthy K, Herlyn M and El-Deiry WS. . 1998 Intl. J. Oncol. 13: 5–9.

  • Roth J, Dobbelstein M, Freedman DA, Shenk T and Levine AJ. . 1998 EMBO J. 17: 554–564.

  • Sambrook J, Fritsch EF and Maniatis T. . 1989 Cold Spring Harbor Laboratory Press. 16: 66–67.

  • Schmale H and Bamberger C. . 1997 Oncogene 15: 1363–1367.

  • Shikama N, Lyon J and La Thangue NB. . 1997 Trends Cell Biology 7: 230–236.

  • Sunahara M, Ichimiya S, Nimura Y, Takada N, Sakiyama S, Sato Y, Todo S, Adachi W, Amano J and Nakagawara A. . 1998 Intl. J. Oncol. 13: 319–323.

  • Takahashi H, Ichimiya S, Nimura Y, Watanabe M, Furusato M, Wakui S, Yatani R, Aizawa S and Nakagawara A. . 1998 Cancer Res. 58: 2076–2077.

  • Waldman T, Kinzler KW and Vogelstein B. . 1995 Cancer Res. 55: 5187–5190.

  • Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dötsch V, Andrews NC, Caput D and McKeon F. . 1998 Mol. Cell. 2: 305–316.

  • Yuan W, Condorelli G, Caruso M, Felsani A and Giordano A. . 1996 J. Biol. Chem. 271: 9009–9013.

Download references

Acknowledgements

We thank our colleagues for helpful comments on this manuscript and Marie Caldwell for help in its preparation and thank D Caput, A Giordano, JR Nevins, M Oren, C Prives and B Vogelstein for plasmids and reagents. This research was supported by the MRC and Prolifix Ltd.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, CW., La Thangue, N. Promoter specificity and stability control of the p53-related protein p73. Oncogene 18, 4171–4181 (1999). https://doi.org/10.1038/sj.onc.1202793

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202793

Keywords

This article is cited by

Search

Quick links